How many atrial fibrillation ablation candidates have an underlying supraventricular tachycardia previously unknown? Efficacy of isolated triggering arrhythmia ablation

Europace

Volumn 12, Issue 12, 2010, Pages 1707-1712

  Sciarra, Luigi ^a   Rebecchi, Marco ^a   De Ruvo, Ermenegildo ^a   De Luca, Lucia ^a   Zuccaro, Lorenzo Maria ^a   Fagagnini, Alessandro ^a   Cor, Leonardo ^b   Allocca, Giuseppe ^b   Lioy, Ernesto ^a   Delise, Pietro ^b   Cal, Leonardo ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b IRCCS E Medea Scientific Institute   (Italy)

Author keywords

Ablation; Atrial fibrillation; Supraventricular tachycardia

Indexed keywords

ADULT; ARTICLE; CATHETER ABLATION; ELECTROPHYSIOLOGY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; SUPRAVENTRICULAR TACHYCARDIA;

ADULT; AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RECURRENCE; RETROSPECTIVE STUDIES; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME;

EID: 78649340159     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq327     Document Type: Article

References (48)

1. Haissaguerre M,Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G et al. Spon-taneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66.
2. Gerstenfeld EP, Sauer W, Callans DJ, Dixit S, Lin D, Russo AM et al. Predictors of success after selective pulmonary vein isolation of arrhythmogenic pulmonary veins for treatment of atrial fibrillation. Heart Rhythm 2006;3:165-70.
3. Marrouche NF, Martin DO, Wazni O, Gillinov AM, Klein A, Bhargava M et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcomes and complications. Circulation 2003;107:2710-6.
4. Gerstenfeld EP, Callans DJ, Dixit S, Zado E, Marchlinski FE. Incidence and location of focal atrial fibrillation triggers in patients undergoing repeat pulmonary vein iso-lation: implication for ablation strategies. J Cardiovasc Electrophysiol 2003;13:685-90.
5. Weiss R, Knight BP, Bahu M, Zivin A, Souza J, Goyal R et al. Long-term follow up after radiofrequency ablation of paroxysmal supraventricular tachycardia in patients with tachycardia-induced AF. Am J Cardiol 1997;80:1609-10.
6. Brugada J, Mont L, Matas M, Navarro-Lopez F. Atrial fibrillation induced by atrio-ventricular nodal reentrant tachycardia. Am J Cardiol 1997;79:681-2.
7. Delise P, Gianfranchi L, Paparella N, Brignole M, Menozzi C, Themistoclakis S et al. Clinical usefulness of slow pathway ablation in patients with both paroxysmal atrioventricular nodal reentrant tachycardia and atrial fibrillation. Am J Cardiol 1997;79:1421-3.
8. Katritsis DG, Giazitzoglou E, Wood MA, Shepard RK, Parvez B, Ellenbogen KA. Inducible supraventricular tachycardias in patients referred for catheter ablation of AF. Europace 2007;9:785-9.
9. Sauer WH, Alonso C, Zado E, Cooper JM, Lin D, Dixit S et al. Atrioventricular nodal reentrant tachycardia in patients referred for AF ablation. Response to abla-tion that incorporates slow-pathway modification. Circulation 2006;114:191-5.
10. Dagres N, Clague JR, Lottkamp H, Hindricks G, Breithardt G, Borggrefe M. Impact of radiofrequency catheter ablation of accessory pathways on the frequency of atrial fibrillation during long-term follow-up: high recurrence rate of atrial fibrilla-tion in patients older than 50 years of age. Eur Heart J 2001;22:423-7.
11. Palma EC, Ferrick KJ, Gross JN, Kim SG, Fisher JD. Transition from atrioventricu-lar node reentry tachycardia to atrial fibrillation begins in the pulmonary veins. Circulation 2000;102:937.
12. Rosso R, Kistler P. Focal atrial tachycardia. Heart 2010;69:181-5.
13. Sciarra L, Corò L, Bocchino M, Sitta N, Marras E, Delise P. Ablation of a single pulmonary vein arrhythmic focus triggering several supraventricular arrhythmias. Ital Heart J 2004;5:946-50.
14. Polymeropoulos KP, Rodriguez LM, Timmermans C, Wellens HJ. Radiofrequency ablation of a focal atrial tachycardia originating from the Marshall ligament as a trigger for atrial fibrillation. Circulation 2002;105:2112-3.
15. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/AHA/ESC 2006guidelines forthe management of patients with atrialfibrillation\executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrilla-tion): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 2006;48:854-906.
16. Josephson MD. Supraventricular tachycardias. In Josephson ME (ed). Clinical Cardiac Electrophysiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p168-71.
17. Jackman WM, Beckman KJ, Mc Clelland JH, Wang X, Friday KJ, Roman CA et al. Treatment of supraventricular tachycardia due to atrioventricular nodal re-entry by radiofrequency catheter ablation of slow pathway conduction. N Eng J Med 1992;327:313-8.
18. Haissaguerre M, Gaita F, Fischer B, Commenges D, Montserrat P, d'Ivernois C et al. Elimination ofatrioventricular nodal re-entranttachycardia using discrete slow poten-tialstoguide application ofradiofrequencyenergy. Circulation 1992;85:2162-75.
19. Chen X, Borggrefe M, Shenasa M, Haverkamp W, Hindricks G, Breithardt G. Characteristics of local electrogram predicting successful transcatheter radiofre-quencyablation of left sided accessory pathways.JAm Coll Cardiol1992;20:656-65.
20. Dagres N, Clague JR, Kottkamp H, Hindricks G, Breithardt G, Borggrefe M. Radio-frequency catheter ablation of accessory pathways. Outcome and use of anti-arrhythmic drugs during follow-up. Eur Heart J 1999;20:1826-32.
21. Kistler PM, Roberts-Thomson KC, Haqqani HM, Fynn SP, Singarayar S, Vohra JK et al. P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol 2006;48:1010-7.
22. Soejima Y, Iesaka Y, Aonuma K, Isobe M. Atrial unipolar potential in radiofre-quency catheter ablation of atrial tachycardia. Int Heart J 2007;48:313-22.
23. Sciarra L, Allocca G, Calò L Use ofelectroanatomic mapping in the assessment of atrial tachycardia aetiology. J Cardiovasc Med 2008;9:1280-1.
24. Wazni OM, Marrouche N, Martin DO, Verma A, Bhargava M, Saliba W et al. Radiofrequency ablation versus antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.JAMA 2005;293:2634-40.
25. Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G et al. Cath-eter ablation treatment in patients with drug-refractory atrial fibrillation: a pro-spective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation Study). Eur Heart J 2006;27:216-21.
26. Haissaguerre M, Gencel L, Fischer B, Le Métayer P, Poquet F, Marcus FI et al. Suc-cessful catheter ablation of atrial fibrillation. J Cardiov Electrophysiol J Cardiovasc Electrophysiol 1994;5:1045-52.
27. Haissaguerre M, Jais P, Shah DC, Gencel L, Pradeau V, Garrigues S et al. Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1996;7:1132-44.
28. Haissaguerre M,Jais P, Shah DC, Garrigue S, Takahashi A, Lavergne T et al. Elec-trophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000;101:1409-17.
29. Pappone C, Oreto G, Lamberti F, Vicedomini G, Loricchio ML, Shpun S et al. Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation 1999;100:1203-8.
30. Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G et al. Circumferential radiofrequency ablation of pulmonary vein ostia. A new anatomic approach for curing atrial fibrillation. Circulation 2000;102:2619-28.
31. Pappone C, Oreto G, Rosanio S, Vicedomini G, Tocchi M, Gugliotta F et al. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patient with atrial fibrillation. Circulation 2001;104:2539-44.
32. Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004;109:327-34.
33. Sueda T, Imai K, Ishii O, Orihashi K, Watari M, Okada K Efficacy of pulmonary vein isolation for the elimination of chronic atrial fibrillation in cardiac valvular surgery. Ann Thorac Surg 2001;71:1189-93.
34. Chen YJ, Chen SA. Electrophysiology of pulmonary veins. J Cardiocvasc Electrophy-siol 2006;17:220-4.
35. Konings KT, Kirchhof CJ, Smeets JR, Wellens HJ, Penn OC, Allessie MA. High-density mappings of electrically induced atrial fibrillation in humans. Circulation 1994;89:1665-80.
36. Allessie MA, Konings K, Kirchhof C, Wijffels M. Electrophysiologic mechanisms of perpetuation of atrial fibrillation. Am J Cardiol 1996;77:10A-23A
37. Wijffels MC, Kirchhof CJ, Dorland R,Alessie MA. Atrialfibrillation begetsatrialfibril-lation. Astudyin awakechronicallyinstrumentedgoats. Circulation 1995;92:1954-68.
38. Ausma J, Wijffels M, Thoné F, Wouters L, Allessie M. Structural changes of atrial myo-cardium due to sustained atrialfibrillation in the goat Circulation 1997;96:3157-63.
39. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J et al. Updated worldwide survey on the methods, efficacy and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3:32-8.
40. Oral H, Chugh A, Good E, Sankaran S, Reich SS, Igic P et al. A Tailored approach to catheter ablation of paroxysmal atrial fibrillation. Circulation 2006;113:1824-31.
41. Oddsson H, Edvardsson N, Walfridsson H. Episodes of atrial fibrillation and atrial vulnerability after successful radiofrequency catheter ablation in patients with Wolff-Parkinson White syndrome. Europace 2002;4:201-6.
42. Centurion OA, Shimizu A, Isomoto S, Konoe A. Mechanism for the genesis of paroxysmal atrial fibrillation in the Wolff-Parkinson-White syndrome: intrinsic atrial muscle vulnerability vs electrophysiological properties of the accessory pathway. Europace 2008;10:294-302.
43. Waldo AL. The interrelationship between atrial fibrillation and atrial flutter. Prog Cardiovasc Dis 2005;48:41-56.
44. Phillipon F, Plumb VJ, Epstein AE, Kay GN. The risk of atrial fibrillation following radiofrequency catheter ablation of atrial flutter. Circulation 1995;92:430-5.
45. Nabar A, Rodriguez LM, Timmermans C, van den Dool A, Smeets JL, Wellens HJ. Effect of right atrial isthmus ablation on the occurrence of atrial fibrillation: obser-vations in four patient groups having type I atrial flutter with or without associ-ated atrialflbrillation. Circulation 1999;99:1441-5.
46. Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S et al. Preven-tion of atrial fibrillation with angiotensin-converting enzyme inhibitors and angio-tensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005;45:1832-9.
47. Madrid AH, Bueno MG, Rebollo JM, Maŕin I, Peña G, Bernal E et al. Use of irbe-sartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibril-lation: a prospective and randomized study. Circulation 2002;106:331-6.
48. Ehrlich JR, Nattel S. Novel approaches for pharmacological management of atrial fibrillation. Drugs 2009;69:757-74.